• Je něco špatně v tomto záznamu ?

Longitudinal analysis of T2 relaxation time variations following radiotherapy for prostate cancer

P. Hanzlikova, D. Vilimek, R. Vilimkova Kahankova, M. Ladrova, V. Skopelidou, Z. Ruzickova, R. Martinek, J. Cvek

. 2024 ; 10 (2) : e24557. [pub] 20240115

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24005930

Aim of this paper is to evaluate short and long-term changes in T2 relaxation times after radiotherapy in patients with low and intermediate risk localized prostate cancer. A total of 24 patients were selected for this retrospective study. Each participant underwent 1.5T magnetic resonance imaging on seven separate occasions: initially after the implantation of gold fiducials, the required step for Cyberknife therapy guidance, followed by MRI scans two weeks post-therapy and monthly thereafter. As part of each MRI scan, the prostate region was manually delineated, and the T2 relaxation times were calculated for quantitative analysis. The T2 relaxation times between individual follow-ups were analyzed using Repeated Measures Analysis of Variance that revealed a significant difference across all measurements (F (6, 120) = 0.611, p << 0.001). A Bonferroni post hoc test revealed significant differences in median T2 values between the baseline and subsequent measurements, particularly between pre-therapy (M0) and two weeks post-therapy (M1), as well as during the monthly interval checks (M2 - M6). Some cases showed a delayed decrease in relaxation times, indicating the prolonged effects of therapy. The changes in T2 values during the course of radiotherapy can help in monitoring radiotherapy response in unconfirmed patients, quantifying the scarring process, and recognizing the therapy failure.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24005930
003      
CZ-PrNML
005      
20240412130858.0
007      
ta
008      
240405s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.heliyon.2024.e24557 $2 doi
035    __
$a (PubMed)38298676
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hanzlikova, Pavla $u Department of Radiology, University Hospital Ostrava, Czech Republic $u Department of Imaging Methods, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
245    10
$a Longitudinal analysis of T2 relaxation time variations following radiotherapy for prostate cancer / $c P. Hanzlikova, D. Vilimek, R. Vilimkova Kahankova, M. Ladrova, V. Skopelidou, Z. Ruzickova, R. Martinek, J. Cvek
520    9_
$a Aim of this paper is to evaluate short and long-term changes in T2 relaxation times after radiotherapy in patients with low and intermediate risk localized prostate cancer. A total of 24 patients were selected for this retrospective study. Each participant underwent 1.5T magnetic resonance imaging on seven separate occasions: initially after the implantation of gold fiducials, the required step for Cyberknife therapy guidance, followed by MRI scans two weeks post-therapy and monthly thereafter. As part of each MRI scan, the prostate region was manually delineated, and the T2 relaxation times were calculated for quantitative analysis. The T2 relaxation times between individual follow-ups were analyzed using Repeated Measures Analysis of Variance that revealed a significant difference across all measurements (F (6, 120) = 0.611, p << 0.001). A Bonferroni post hoc test revealed significant differences in median T2 values between the baseline and subsequent measurements, particularly between pre-therapy (M0) and two weeks post-therapy (M1), as well as during the monthly interval checks (M2 - M6). Some cases showed a delayed decrease in relaxation times, indicating the prolonged effects of therapy. The changes in T2 values during the course of radiotherapy can help in monitoring radiotherapy response in unconfirmed patients, quantifying the scarring process, and recognizing the therapy failure.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vilimek, Dominik $u Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic
700    1_
$a Vilimkova Kahankova, Radana $u Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic
700    1_
$a Ladrova, Martina $u Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic
700    1_
$a Skopelidou, Valeria $u Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, 70852, Ostrava, Czech Republic $u Institute of Molecular and Clinical Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, 70300, Ostrava, Czech Republic
700    1_
$a Ruzickova, Zuzana $u Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic $u Department of Oncology, University Hospital Ostrava, 70852 Ostrava, Czech Republic
700    1_
$a Martinek, Radek $u Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, 17. listopadu 15, Ostrava - Poruba, 708 00, Czech Republic
700    1_
$a Cvek, Jakub $u Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic $u Department of Oncology, University Hospital Ostrava, 70852 Ostrava, Czech Republic
773    0_
$w MED00190064 $t Heliyon $x 2405-8440 $g Roč. 10, č. 2 (2024), s. e24557
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38298676 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240405 $b ABA008
991    __
$a 20240412130850 $b ABA008
999    __
$a ok $b bmc $g 2076071 $s 1215692
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 10 $c 2 $d e24557 $e 20240115 $i 2405-8440 $m Heliyon $n Heliyon $x MED00190064
LZP    __
$a Pubmed-20240405

Najít záznam

Citační ukazatele

Možnosti archivace